Pacer Advisors
COLL icon

Pacer Advisors’s Collegium Pharmaceutical COLL Stock Holding History

Pacer Advisors’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10M Buy
277,282
+20,917
+8% +$715K 0.03% 504
2026
Q1 		$8.48M Buy
256,365
+15,475
+6% +$655K 0.02% 483
2025
Q4 		$11.2M Sell
240,890
-9,711
-4% -$406K 0.03% 464
2025
Q3 		$8.77M Sell
250,601
-87,066
-26% -$3.03M 0.02% 515
2025
Q2 		$9.98M Sell
337,667
-81,409
-19% -$2.32M 0.02% 495
2025
Q1 		$12.5M Sell
419,076
-1,723,415
-80% -$52.7M 0.03% 425
2024
Q4 		$61.4M Sell
2,142,491
-447,157
-17% -$14.8M 0.13% 176
2024
Q3 		$100M Sell
2,589,648
-818,721
-24% -$29.2M 0.21% 129
2024
Q2 		$110M Buy
3,408,369
+821,541
+32% +$28.5M 0.25% 118
2024
Q1 		$100M Buy
2,586,828
+412,110
+19% +$14.4M 0.23% 121
2023
Q4 		$66.9M Buy
2,174,718
+883,380
+68% +$22.1M 0.19% 134
2023
Q3 		$28.9M Buy
1,291,338
+511,692
+66% +$11.7M 0.11% 191
2023
Q2 		$16.8M Buy
779,646
+336,879
+76% +$7.65M 0.07% 267
2023
Q1 		$10.6M Buy
442,767
+141,458
+47% +$3.75M 0.05% 381
2022
Q4 		$6.99M Buy
+301,309
New +$6.08M 0.04% 383
2022
Q2 		– Sell
-220,982
Closed -$4.5M – 2393
2022
Q1 		$4.5M Buy
220,982
+75,090
+51% +$1.42M 0.04% 446
2021
Q4 		$2.73M Buy
145,892
+39,558
+37% +$771K 0.03% 680
2021
Q3 		$2.1M Buy
106,334
+15,932
+18% +$345K 0.03% 656
2021
Q2 		$2.14M Buy
+90,402
New +$2.09M 0.03% 602

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Pacer Advisors's COLL Position: Q2 2026 in Review

Pacer Advisors increased its Collegium Pharmaceutical (COLL) stake by 8.2% in Q2 2026, buying an estimated $715K and bringing the position to 277,282 shares worth $10M. The position accounts for 0.03% of the portfolio, ranked #504.

Pacer Advisors first reported a position in COLL in Q2 2021 and has held it in 19 quarters since. The position peaked at $110M in Q2 2024. 280 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Pacer Advisors held 277,282 shares of Collegium Pharmaceutical worth $10M as of Q2 2026.
  • Pacer Advisors bought 20,917 Collegium Pharmaceutical shares in Q2 2026, an estimated $715K.
  • Collegium Pharmaceutical made up 0.03% of Pacer Advisors's portfolio in Q2 2026, its #504 holding.
  • Pacer Advisors first reported a position in Collegium Pharmaceutical in Q2 2021 and has held it in 19 quarters since.
  • Pacer Advisors's Collegium Pharmaceutical position peaked at $110M in Q2 2024.
  • 280 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.